Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sjacobs26's Profile
Displaying 301-350 of 1161 result(s).
CYDY CytoDyn Inc
12/18/2019 1:54:07 PM
I do....at least many of them. Dr. (1)
CYDY CytoDyn Inc
12/18/2019 1:33:55 PM
Yi Chen has been on most of the cal (1)
CYDY CytoDyn Inc
12/18/2019 1:29:23 PM
Yes, NP said he wasn’t going to t (1)
CYDY CytoDyn Inc
12/18/2019 1:13:38 PM
Nice list of highlights, but I thin (1)
CYDY CytoDyn Inc
12/18/2019 1:11:34 PM
Seems the milestones for BLA submis (2)
CYDY CytoDyn Inc
12/18/2019 1:00:02 PM
Good interview IMO. It clarified a (3)
CYDY CytoDyn Inc
12/18/2019 12:49:20 PM
BOD (Mr. Klump and his advisors) ve (3)
CYDY CytoDyn Inc
12/18/2019 12:43:15 PM
If the deal struck aligns with what (1)
CYDY CytoDyn Inc
12/18/2019 11:07:48 AM
Great question, and would be nice t (6)
CYDY CytoDyn Inc
12/17/2019 7:45:13 PM
They’re private, so unfortunately
CYDY CytoDyn Inc
12/17/2019 10:32:08 AM
Like you, I’m not expecting BLA s (1)
CYDY CytoDyn Inc
12/16/2019 6:04:46 PM
If you are talking milestone paymen (2)
CYDY CytoDyn Inc
12/16/2019 10:32:28 AM
Two things that stood out as the pr (1)
CYDY CytoDyn Inc
12/14/2019 3:01:51 PM
I’m not 100% whether or not this
CYDY CytoDyn Inc
12/14/2019 12:48:40 PM
Yes, CYDY purchased Pro-140 (now le (1)
CYDY CytoDyn Inc
12/13/2019 2:48:11 PM
I couldn't agree more craig. Detail (1)
CYDY CytoDyn Inc
12/12/2019 10:01:47 PM
Thanks ohm for providing the non-me (1)
CYDY CytoDyn Inc
12/12/2019 1:10:16 PM
I don't recall discussion on this s
CYDY CytoDyn Inc
12/12/2019 12:32:12 PM
Thanks ohm, yes I recall the mucosa
CYDY CytoDyn Inc
12/12/2019 11:52:26 AM
I know you have already received so
CYDY CytoDyn Inc
12/11/2019 9:16:54 PM
I believe it is 12 years protection
CYDY CytoDyn Inc
12/11/2019 3:05:33 PM
It would be severely disappointing (1)
CYDY CytoDyn Inc
12/11/2019 2:55:34 PM
Furthermore, the chemotherapy resis (1)
CYDY CytoDyn Inc
12/11/2019 1:55:50 PM
Thank you Trding (and ohm from prev (1)
CYDY CytoDyn Inc
12/11/2019 11:15:34 AM
Those are some valid points Fortuno (3)
CYDY CytoDyn Inc
12/11/2019 10:53:28 AM
Here's an example of a P2 cancer dr (1)
CYDY CytoDyn Inc
12/10/2019 9:08:20 AM
I thought the same thing and seems
CYDY CytoDyn Inc
12/09/2019 10:09:26 PM
I like this idea much better than c
CYDY CytoDyn Inc
12/09/2019 9:55:45 PM
Yes, with no pipeline, other produc
CYDY CytoDyn Inc
12/09/2019 9:37:01 PM
Similar to what PGNX and AbbVie are
CYDY CytoDyn Inc
12/09/2019 7:24:35 PM
Yes, I agree it smells like they ar
CYDY CytoDyn Inc
12/09/2019 5:09:03 PM
My thoughts too. Possibly transitio (3)
CYDY CytoDyn Inc
12/09/2019 2:18:59 PM
Very well-articulated and I agree w
CYDY CytoDyn Inc
12/09/2019 2:05:13 PM
There has been speculation of compe (1)
CYDY CytoDyn Inc
12/09/2019 1:45:38 PM
Why is it not possible for us to ge
CYDY CytoDyn Inc
12/09/2019 1:26:07 PM
Would be nice if this story grows l (1)
CYDY CytoDyn Inc
12/09/2019 12:51:41 PM
I'm indifferent whether PrEP is inc (2)
CYDY CytoDyn Inc
12/09/2019 12:18:00 PM
Seems pretty clear that PrEP is als (1)
CYDY CytoDyn Inc
12/09/2019 12:13:00 PM
Association of a novel circulating (2)
CYDY CytoDyn Inc
12/09/2019 10:08:36 AM
Exactly, even if it has happened pr
CYDY CytoDyn Inc
12/09/2019 9:34:51 AM
One has to be both highly naive and (4)
CYDY CytoDyn Inc
12/05/2019 8:54:06 PM
IMO (based on DD) there is little d
CYDY CytoDyn Inc
12/05/2019 1:41:10 PM
The science is (hopefully) undoubte (4)
CYDY CytoDyn Inc
12/04/2019 12:17:26 PM
For a comic relief: maybe RP sold t (1)
CYDY CytoDyn Inc
12/03/2019 2:39:48 PM
That is not my understanding. I thi
CYDY CytoDyn Inc
12/03/2019 2:34:19 PM
I just hope that the science is rea (1)
CYDY CytoDyn Inc
12/03/2019 11:44:39 AM
Exactly, warrant accumulation in fu (1)
CYDY CytoDyn Inc
12/03/2019 10:15:31 AM
We have had many patients contact u (1)
CYDY CytoDyn Inc
12/03/2019 10:03:30 AM
Would the FDA give the green light
CYDY CytoDyn Inc
12/03/2019 9:35:29 AM
Nice call on the TNBC PR yesterday! (2)
Go to page:
  • << First
  • < Previous
  • 6
  • 7
  • Next >

Recent Articles

  • Broadridge Financial Solutions Elevates Leadership Roles
  • Insights into Clifton Mining Company's Production Surge
  • Soligenix Achieves Successful Manufacturing of Synthetic Hypericin
  • Calamos Aksia CAPVX Fund: A Game-Changer in Investment Strategy
  • Alphyn Biologics Unveils Zabalafin Hydrogel Breakthrough
  • Aebi Schmidt Group Emerges from Successful Merger with Shyft
  • Sobi Expands Alliance with Apellis for Aspaveli Royalties
  • Empowering Lives: New Campaign for Bronchiectasis Awareness
  • Red Cross and Armed Services Team Up for Blood Donation Drive
  • Adagene Secures Major Investment from Sanofi for Future Growth
  • Close-Up International Welcomes Jim Barone as Executive VP
  • Banzai Announces Multi-Million Dollar Debt Financing Deal
  • Avacta Enriches Leadership with New Appointments and Strategy
  • McDermott Partners with Universiti Malaysia Sabah for Growth
  • Bobby Bonilla's Big Deal: A New Perspective on Financial Security
  • Celebrating Art and Whiskey: Breckenridge's Unique Collaboration
  • Innovative Partnership for Enhanced Edge AI Solutions Announced
  • Strategic Growth at Amalgamated Financial with New Appointments
  • Consumer Advocacy Calls Out Misleading USA Claims by Renewal
  • Proxy Firms Advocate for Brookdale's Board Stability Amidst Challenges
  • Maglite® Partners to Enhance Pedestrian Safety Awareness
  • Thunder Power Holdings Expands with Strategic Share Acquisition
  • Ark Invest Sees a Bright Future for Crypto in Mortgage Applications
  • Investing Insights on Booz Allen Hamilton and Nike's Future
  • Historic Simón Bolívar Flintlock to be Auctioned Soon
  • ePlus Inc. Completes Strategic Sale of Financing Division
  • Fidelis Capital Expands Team with Industry Veteran Paul Trippe
  • Concerns Intensify Over Corporate Control at Brookdale Ahead
  • Nektar Therapeutics Sets $100 Million Public Offering Price
  • Innovative Investments: Maldives Partners with Henley & Partners
  • Raising Awareness About the Risks of Toxic Mold Exposure
  • TPMS Market Growth Insights: USD 8.94 Billion by 2024
  • Discover the Travel-Ready Crypto Card by OppiWallet
  • Abeona Therapeutics Expands Workforce with New Equity Grants
  • Apellis Pharmaceuticals Secures $300 Million Royalty Deal
  • Verrica Pharmaceuticals Advances Global Trials for YCANTH® Treatment
  • Banzai Expands Financial Horizons with New Debt Facility
  • Amaroq Minerals Ltd. Joins OTCQX for Enhanced Trading Opportunities
  • NewGen's Strategic Land Acquisition and Blockchain Exploration
  • Key Takeaways from Bitfarms’ Annual Shareholders Meeting
  • Nutriband Inc. Celebrates Its Addition to Multiple Russell Indexes
  • Stephanie Plant Assumes Leadership at WTAP for Gray Media
  • BioXcel Therapeutics Advances Innovative Biopharma Research
  • Adagene Secures $25 Million Investment for Future Clinical Trials
  • Leadership Transition at Jade Biosciences: A New Era Begins
  • Amalgamated Financial Expands Board with Industry Leaders
  • Green Sands Equity Appoints Eric Sarasin as Partner
  • Prospect Capital Completes QC Holdings Acquisition Successfully
  • H.I.G. Capital Expands Portfolio with 4Refuel Acquisition
  • Marex Group Enhances FX Service with Hamilton Court Acquisition
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site